<DOC>
	<DOCNO>NCT02470247</DOCNO>
	<brief_summary>Diagnostic imaging vascular investigation endovascular procedure frequently require use contrast medium . Besides contrast medium-induced hypersensitivity , acute kidney injury appear : contrast-induced nephropathy ( NPCI ) . NPCI associated increase patient ' morbidity mortality . One conventional method propose limit NPCI oral administration N-acetylcysteine ( NAC ) associate hydration perform 12 hour 12 hour injection . However , patient method perform due high risk heart failure although generally high risk NPCI . Recently , show , randomize trial , remote ischemic preconditioning ( several cycle upper-arm ischemia-reperfusion pressure cuff inflator ) associate hydratation NAC reduce occurrence NPCI coronary angiography compare NAC hydration . . We hypothesize use RIPC patient high risk NPCI receive NAC hydratation ( e.g . patient aortic stenosis eligible Transcatheter Aortic Valve Implantation ( TAVI ) ) could promise .</brief_summary>
	<brief_title>Interest Remote Ischemic Preconditioning Prevention Contrast Medium-induced Nephropathy High Risk Patients</brief_title>
	<detailed_description>Study design : Prospective , single-center , randomize , control , single-blind , RIPC procedure ( Pre-CI ) versus `` SHAM '' ischemic preconditioning ( SHAM Pre -CI ) ( control ) . This test follow CONSORT Statement ( http : //www.consort-statement.org/ ) . This randomize , control , single-blind trial , assess incidence NPCI ( CTA ) two group patient , one receiving RIPC procedure group receive `` SHAM '' RIPC ( control group ) . RIPC accomplish perform 4 cycle alternate 5-minute inflation 5-minute deflation standard upper-arm blood pressure cuff , induce transient repetitive arm ischemia reperfusion . RIPC start CTA , time last inflation cycle begin CTA le 45 minute . The `` SHAM '' RIPC carry number cycle RIPC cuff inflate diastolic pressure subject cuff deflate to10 mmHg order maintain non- ischemic compression ( blind patient protocol ) . Main objective : To assess efficacy remote ischemic preconditioning ( RIPC ) prevent contrast-induced nephropathy ( NPCI ) inject CT scanner patient high risk NPCI . Secondary objective : 1 . To assess effect RIPC second marker renal failure ( Cystatin C ) ; 2 . To determine pathophysiological mechanism involve RIPC ( role oxidative stress ; first 40 patient ) ; 3 . To assess effect RIPC renal function second injection contrast-medium coronary angiography perform 2 4 day inject CTA ; 4 . To assess tolerance RIPC procedure ; 5 . To assess impact mortality 6 month .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<criteria>Age great 18 year , upper age limit ; Patient may hospitalize medical checkup percutaneous aortic valve implantation ( CTA coronarography ) ; Patient risk NPCI define Mehran risk classification system â‰¥11 ( Annexe 2 ) ; Willing provide free inform write consent Pathology upperlimbs limit use cuff ( bilateral amputation , arteriovenous fistula ) ; Critical renal disease require hemodialysis ; Person affiliate health care system insurance Inability understand instruction study ; Absolute contraindication iodinate contrast medium injection ( anaphylactic shock history contrast medium , especially Xenetix , clearance ( MDRD ) less 30mL/min/1.73m2 ) ; Pregnancy Simultaneous participation protocol ; Person legal protection , person deprive liberty .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Transcatheter Aortic Valve Implantation</keyword>
</DOC>